GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inovio Pharmaceuticals Inc (FRA:GBM) » Definitions » Short Percentage of Float

Inovio Pharmaceuticals (FRA:GBM) Short Percentage of Float


View and export this data going back to 2005. Start your Free Trial

What is Inovio Pharmaceuticals Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Inovio Pharmaceuticals's Short Percentage of Float

For the Biotechnology subindustry, Inovio Pharmaceuticals's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Inovio Pharmaceuticals's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Inovio Pharmaceuticals's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Inovio Pharmaceuticals's Short Percentage of Float falls into.


Inovio Pharmaceuticals (FRA:GBM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inovio Pharmaceuticals Inc (FRA:GBM) » Definitions » Short Percentage of Float
Comparable Companies
MGNX AGEN XERS EPIX RVNC INZY PSTX CRMD XOMA MRSN OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
INO:USA INO:Mexico
Address
660 West Germantown Pike, Suite 110, Plymouth Meeting, PA, USA, 19462
Website
https://www.inovio.com
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Inovio Pharmaceuticals (FRA:GBM) Headlines

No Headlines